Results 61 to 70 of about 84,964 (303)
Botulinum Toxin in the Treatment of Lingual Dystonia Induced by Speaking
Case Reports in Neurology, 2013 Primary lingual dystonia is a rare condition, especially when it is only induced by speaking. Trihexyphenidyl failed to improve the symptoms. Several case series have demonstrated the effectiveness of botulinum toxin injection for the management of focal
F. Budak +3 more
doaj +1 more source
Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial [PDF]
, 2012 Stroke imposes significant burdens on health services and society, and as such there is a growing need to assess the cost-effectiveness of stroke treatment to ensure maximum benefit is derived from limited resources.
Christopher Price +16 more
core +3 more sources
The Mental Health Impact of Retrograde Cricopharyngeus Dysfunction (RCPD) and Its Treatment
The Laryngoscope, EarlyView.This study assessed the prevalence of anxiety and depression within patients with retrograde cricopharyngeus dysfunction (RCPD) while evaluating the impact of cricopharyngeal botulinum toxin injection (CPBTI) on associated symptoms. Using validated surveys for anxiety and depression given at specific time intervals, RCPD patients were found to have a ...
Alexander P. Simko, Andrew G. Tritter
wiley +1 more source
Treatment of the Spasticity in Children with Cerebral Palsy
Biomolecules & Biomedicine, 2008 Botulinum toxin is a natural purified protein and one of the strongest biological poisons - neurotoxin. It is produced by the bacterium Clostridium botulinum. Its medical usage started in USA in 1981 and in Europe in 1992.
Ajša Meholjić-Fetahović
doaj +1 more source
Outcomes in the Management of Pediatric Retrograde Cricopharyngeal Dysfunction
The Laryngoscope, EarlyView.ABSTRACT Objective To review the presentation and treatment outcomes of pediatric patients with retrograde cricopharyngeal dysfunction (RCPD). Methods A retrospective chart review was performed on pediatric patients diagnosed with retrograde cricopharyngeal dysfunction (RCPD) and treated with cricopharyngeal botulinum toxin injection (CPBTI).
Aidan P. Wright +3 more
wiley +1 more source
Botulinum toxin type A for Holmes tremor secondary to thalamic hemorrhage [PDF]
, 2015 Holmes tremor (HT) is a low-frequency rest and intentional tremor frequently affecting the upper limb.
Giovannelli, Morena +3 more
core +1 more source
Botulinum toxin treatment of urethral and bladder dysfunction. [PDF]
, 2002 Tremendous excitement has been generated by the use of botulinum toxin for the treatment of various types of urethral and bladder dysfunction over the past several years. Botulinum toxin is the most lethal naturally occurring toxin known to mankind. Why,
Chancellor, Michael B +4 more
core +1 more source
Movement Disorders Clinical Practice, EarlyView.ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan +4 more
wiley +1 more source
, 2003 The utility of the htrA, pagC and nirB promoters to direct the expression of the carboxy-terminal (H(C)) fragment of botulinum toxin F (FH(C)) in Salmonella enterica var Typhimurium has been evaluated. Only low levels of serum antibody were induced after
Fairweather, Neil F +4 more
core +1 more source
Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study [PDF]
, 2017 To evaluate the role of botulinum toxin type A (BTX-A) in the treatment of pain associated with nocturnal bruxism. Fifty subjects reporting nocturnal bruxism were recruited for a randomized clinical trial. Twenty five bruxers were injected with botulinum
Al Wayli, Hessa
core +1 more source